Cargando…

The Impact of Human Platelet Antigen Allele on Antiplatelet Antibodies and Cryoglobulins in Patients with Primary Immune Thrombocytopenia and Hepatitis C Virus-Associated Immune Thrombocytopenia

BACKGROUND AND OBJECTIVES: Human platelet antigens (HPAs) are alloantigens associated with antiplatelet alloantibodies and the risk of immune thrombocytopenia (ITP). However, few studies have investigated associations among HPAs, antiplatelet autoantibodies, and cryoglobulins. METHODS: We enrolled 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Cih-En, Chen, Yi-Yang, Chang, Jung-Jung, Wu, Yu-Ying, Chen, Wei-Ming, Wang, Ying-Hsuan, Chen, Min-Chi, Lu, Chang-Hsien, Shi, Chung-Sheng, Chen, Chih-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171212/
https://www.ncbi.nlm.nih.gov/pubmed/37180208
http://dx.doi.org/10.4084/MJHID.2023.030
_version_ 1785039381422145536
author Huang, Cih-En
Chen, Yi-Yang
Chang, Jung-Jung
Wu, Yu-Ying
Chen, Wei-Ming
Wang, Ying-Hsuan
Chen, Min-Chi
Lu, Chang-Hsien
Shi, Chung-Sheng
Chen, Chih-Cheng
author_facet Huang, Cih-En
Chen, Yi-Yang
Chang, Jung-Jung
Wu, Yu-Ying
Chen, Wei-Ming
Wang, Ying-Hsuan
Chen, Min-Chi
Lu, Chang-Hsien
Shi, Chung-Sheng
Chen, Chih-Cheng
author_sort Huang, Cih-En
collection PubMed
description BACKGROUND AND OBJECTIVES: Human platelet antigens (HPAs) are alloantigens associated with antiplatelet alloantibodies and the risk of immune thrombocytopenia (ITP). However, few studies have investigated associations among HPAs, antiplatelet autoantibodies, and cryoglobulins. METHODS: We enrolled 43 patients with primary ITP, 47 with hepatitis C virus-associated ITP (HCV-ITP), 21 with hepatitis B virus-associated ITP (HBV-ITP), 25 controls with HCV, and 1013 normal controls. We analyzed HPA allele frequencies, including HPA1-6 and 15, antiplatelet antibodies binding to platelet glycoprotein (GP) IIb/IIIa, Ia/IIa, Ib/IX, IV, human leukocyte antigen class I, cryoglobulin IgG/A/M, and their associations with thrombocytopenia. RESULTS: In the ITP cohort, HPA2ab, rather than HPA2aa, predicted a low platelet count. HPA2b was associated with the risk of developing ITP. HPA15b was correlated with multiple antiplatelet antibodies. In HCV-ITP patients, HPA3b was correlated with anti-GPIIb/IIIa antibodies. HCV-ITP patients with anti-GPIIb/IIIa antibodies had a higher positive rate of cryoglobulin IgG and IgA compared with those without anti-GPIIb/IIIa antibodies. Overlapping detection was also found among other antiplatelet antibodies and cryoglobulins. Like the antiplatelet antibodies, cryoglobulins were associated with clinical thrombocytopenia, implying their close relationship. Finally, we extracted cryoglobulins to confirm the exhibition of cryoglobulin-like antiplatelet antibodies. In contrast, in primary ITP patients, HPA3b was correlated with cryoglobulin IgG/A/M rather than anti-GPIIb/IIIa antibodies. CONCLUSION: HPA alleles were associated with antiplatelet autoantibodies and had different impacts in primary ITP and HCV-ITP patients. HCV-ITP was considered to be a symptom of mixed cryoglobulinemia in HCV patients. The pathophysiology may differ between these two groups.
format Online
Article
Text
id pubmed-10171212
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-101712122023-05-11 The Impact of Human Platelet Antigen Allele on Antiplatelet Antibodies and Cryoglobulins in Patients with Primary Immune Thrombocytopenia and Hepatitis C Virus-Associated Immune Thrombocytopenia Huang, Cih-En Chen, Yi-Yang Chang, Jung-Jung Wu, Yu-Ying Chen, Wei-Ming Wang, Ying-Hsuan Chen, Min-Chi Lu, Chang-Hsien Shi, Chung-Sheng Chen, Chih-Cheng Mediterr J Hematol Infect Dis Original Article BACKGROUND AND OBJECTIVES: Human platelet antigens (HPAs) are alloantigens associated with antiplatelet alloantibodies and the risk of immune thrombocytopenia (ITP). However, few studies have investigated associations among HPAs, antiplatelet autoantibodies, and cryoglobulins. METHODS: We enrolled 43 patients with primary ITP, 47 with hepatitis C virus-associated ITP (HCV-ITP), 21 with hepatitis B virus-associated ITP (HBV-ITP), 25 controls with HCV, and 1013 normal controls. We analyzed HPA allele frequencies, including HPA1-6 and 15, antiplatelet antibodies binding to platelet glycoprotein (GP) IIb/IIIa, Ia/IIa, Ib/IX, IV, human leukocyte antigen class I, cryoglobulin IgG/A/M, and their associations with thrombocytopenia. RESULTS: In the ITP cohort, HPA2ab, rather than HPA2aa, predicted a low platelet count. HPA2b was associated with the risk of developing ITP. HPA15b was correlated with multiple antiplatelet antibodies. In HCV-ITP patients, HPA3b was correlated with anti-GPIIb/IIIa antibodies. HCV-ITP patients with anti-GPIIb/IIIa antibodies had a higher positive rate of cryoglobulin IgG and IgA compared with those without anti-GPIIb/IIIa antibodies. Overlapping detection was also found among other antiplatelet antibodies and cryoglobulins. Like the antiplatelet antibodies, cryoglobulins were associated with clinical thrombocytopenia, implying their close relationship. Finally, we extracted cryoglobulins to confirm the exhibition of cryoglobulin-like antiplatelet antibodies. In contrast, in primary ITP patients, HPA3b was correlated with cryoglobulin IgG/A/M rather than anti-GPIIb/IIIa antibodies. CONCLUSION: HPA alleles were associated with antiplatelet autoantibodies and had different impacts in primary ITP and HCV-ITP patients. HCV-ITP was considered to be a symptom of mixed cryoglobulinemia in HCV patients. The pathophysiology may differ between these two groups. Università Cattolica del Sacro Cuore 2023-05-01 /pmc/articles/PMC10171212/ /pubmed/37180208 http://dx.doi.org/10.4084/MJHID.2023.030 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Huang, Cih-En
Chen, Yi-Yang
Chang, Jung-Jung
Wu, Yu-Ying
Chen, Wei-Ming
Wang, Ying-Hsuan
Chen, Min-Chi
Lu, Chang-Hsien
Shi, Chung-Sheng
Chen, Chih-Cheng
The Impact of Human Platelet Antigen Allele on Antiplatelet Antibodies and Cryoglobulins in Patients with Primary Immune Thrombocytopenia and Hepatitis C Virus-Associated Immune Thrombocytopenia
title The Impact of Human Platelet Antigen Allele on Antiplatelet Antibodies and Cryoglobulins in Patients with Primary Immune Thrombocytopenia and Hepatitis C Virus-Associated Immune Thrombocytopenia
title_full The Impact of Human Platelet Antigen Allele on Antiplatelet Antibodies and Cryoglobulins in Patients with Primary Immune Thrombocytopenia and Hepatitis C Virus-Associated Immune Thrombocytopenia
title_fullStr The Impact of Human Platelet Antigen Allele on Antiplatelet Antibodies and Cryoglobulins in Patients with Primary Immune Thrombocytopenia and Hepatitis C Virus-Associated Immune Thrombocytopenia
title_full_unstemmed The Impact of Human Platelet Antigen Allele on Antiplatelet Antibodies and Cryoglobulins in Patients with Primary Immune Thrombocytopenia and Hepatitis C Virus-Associated Immune Thrombocytopenia
title_short The Impact of Human Platelet Antigen Allele on Antiplatelet Antibodies and Cryoglobulins in Patients with Primary Immune Thrombocytopenia and Hepatitis C Virus-Associated Immune Thrombocytopenia
title_sort impact of human platelet antigen allele on antiplatelet antibodies and cryoglobulins in patients with primary immune thrombocytopenia and hepatitis c virus-associated immune thrombocytopenia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171212/
https://www.ncbi.nlm.nih.gov/pubmed/37180208
http://dx.doi.org/10.4084/MJHID.2023.030
work_keys_str_mv AT huangcihen theimpactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT chenyiyang theimpactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT changjungjung theimpactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT wuyuying theimpactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT chenweiming theimpactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT wangyinghsuan theimpactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT chenminchi theimpactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT luchanghsien theimpactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT shichungsheng theimpactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT chenchihcheng theimpactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT huangcihen impactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT chenyiyang impactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT changjungjung impactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT wuyuying impactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT chenweiming impactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT wangyinghsuan impactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT chenminchi impactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT luchanghsien impactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT shichungsheng impactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia
AT chenchihcheng impactofhumanplateletantigenalleleonantiplateletantibodiesandcryoglobulinsinpatientswithprimaryimmunethrombocytopeniaandhepatitiscvirusassociatedimmunethrombocytopenia